Biotechrabbit
Private Company
Total funding raised: $20M
Overview
Biotechrabbit is an established, privately-held life science tools and services company with over three decades of operation. It has built a diversified portfolio spanning PCR reagents, nucleic acid purification, proteomics tools, and antibody services, catering primarily to research and diagnostic markets. The company emphasizes quality, customization, and partnership, holding ISO 13485 and ISO 9001 certifications, which positions it as a qualified supplier for regulated applications. Its business model is focused on providing products and contract services rather than developing its own therapeutic pipeline.
Technology Platform
Integrated capabilities in molecular biology and protein biochemistry reagent manufacturing, including enzyme production, custom antibody development, protein purification tools, and cell-free protein synthesis systems.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Biotechrabbit competes in a fragmented but crowded market dominated by large multinational corporations like Thermo Fisher Scientific, Merck, and Qiagen. Its competitive advantage lies in its specialization, flexibility for customization, high-quality certifications (ISO 13485), and direct service model, targeting customers who may be underserved by the one-size-fits-all approach of larger players.